Dlzip itself is hyperphosphorylated. The newly tyrosine phosphorylated proteins and activated Src-family members appear to be associated with actinrich lamellipodia. A point mutation that alters the SH3-binding motif of AFAP-110
Introduction
Activation of the Src oncogene is associated with characteristic changes in the actin cytoskeleton of cultured cells (Felice et al., 1990; Hamaguchi and Hanafusa, 1987; Reynolds et al., 1989) . These changes include a repositioning of actin ®laments into rosettelike structures, and the formation of lamellipodia and ®lopodia, which are associated with increased cell motility and the onset of tumor metastasis in humans (Bolen et al., 1987; Boschek et al., 1981; Cartwright et al., 1990; Irby et al., 1999; Rosen et al., 1986; Tarone et al., 1985) . The cSrc proto-oncogene can be activated by dephosphorylation of Tyr 527 by cellular phosphatases, or displacement of repressive, intramolecular interactions involving the SH2 and SH3 domains (Brown and Cooper, 1996) . These activation events normally occur in response to cellular signals, e.g., growth factors interacting with their receptors (Brown and Cooper, 1996) . These pathways are thought to proceed through Src, with the subsequent phosphorylation of substrates and activation of downstream signaling members, including Ras (He et al., 2000) , pp125
FAK (Thomas et al., 1998) , Crk (Sabe et al., 1992 ) and pp130
Cas (Xing et al., 2000) . The actin ®lament associated protein, AFAP-110, is a tyrosine phosphorylated substrate of Src and an SH2/SH3 binding partner for Src 527F (Flynn et al., 1993) . AFAP-110 is also capable of being an SH2/SH3 binding partner for cFyn and cLyn (Flynn et al., 1993; Guappone and Flynn, 1997) . AFAP-110 appears to function as an adaptor molecule, linking other proteins to the actin cytoskeleton, potentially in multi-protein complexes. AFAP-110 contains several putative protein binding domains, including SH2 and SH3 binding motifs, two pleckstrin homology (PH) domains, and a leucine zipper (Flynn et al., 1993) . Additionally, AFAP-110 contains a carboxy terminal, actin-binding domain (Qian et al., 2000) . These data indicate that AFAP-110 could function by serving to link Src, as well as a variety of other signaling proteins, to actin ®laments.
The presence of a leucine zipper motif indicated a mechanism by which AFAP-110 could self-associate (Qian et al., 1998) . Cellular AFAP-110 can be anity absorbed from cell lysates with GST-encoded fusion proteins expressing the leucine zipper motif; however, coexpression of Src 527F abrogated the ability of these fusion proteins to absorb cellular AFAP-110. Gel ®ltration analysis con®rmed that AFAP-110 does exist in a selfassociated, multimeric complex as tetramers, trimers and also monomers and that the leucine zipper was necessary for multimerization (Flynn et al., 2001; Qian et al., 1998) . Co-expression of Src 527F reduces the size of selfassociated AFAP-110 complexes to a single population hypothesized to represent dimers (Qian et al., 1998) . Because there appeared to be a change in conformation of AFAP-110 in response to Src 527F signaling that eected the leucine zipper motif, this same motif was deleted (AFAP-110 Dlzip to exist as a dimer, based upon gel ®ltration analysis (Baisden et al., 2001) . In cells, expression of AFAP-110
Dlzip aected a signi®cant change in cell morphology and actin ®lament integrity, repositioning actin ®laments into rosette-like structures, not unlike those seen in Src-transformed cells, and inducing lamellipodia formation (Qian et al., 1998 (Qian et al., , 2000 . Thus, AFAP-110 has an intrinsic capability to alter actin ®lament integrity, which may be revealed by cellular signals which direct changes in its conformation.
In this study, we hypothesized that AFAP-110
Dlzip could direct changes in actin ®lament integrity either directly or indirectly. A direct mechanism was de®ned as one in which AFAP-110 alters actin ®lament integrity by virtue of an ability to physically bind and remodel actin ®laments. An indirect mechanism was de®ned as one in which AFAP-110 activated cellular signaling pathways known to modulate actin ®lament integrity. The results shown here indicate that AFAP-110 Dlzip induces the activation of cellular tyrosine kinases, including Src-family members and, thus, repositions actin ®laments into rosettes via an indirect mechanism. These events are blocked by two separate genetic alterations in AFAP-110; one a mutation in the SH3-binding motif, AFAP-110 P71A/Dlzip , the second a deletion in an amino-terminal pleckstrin homology (PH) domain, AFAP-110
, neither of which could direct an increase in steady-state levels of tyrosine phosphorylation or Src family activation, and neither of which eected actin ®lament integrity. Co-expression of constitutively active Rho (RhoA   V14   ) overcomes the ability of AFAP-110
Dlzip to alter actin ®laments without aecting the activation of Src or cellular tyrosine phosphorylation by this mutant, indicating the eects of AFAP-110
Dlzip to generate actin rosettes and lamellipodia can occur via its ability to activate signaling cascades that regulate actin ®laments. We hypothesize that AFAP-110 has the potential to alter actin ®laments in response to cellular signals that would alter its conformation, resulting in activation of cellular kinases via its ability to interact with SH3-containing and PH domain-binding partners.
Results
Deletion of the leucine zipper motif enables AFAP-110 to alter actin filament integrity
The expression of AFAP-110
Dlzip results in a cell phenotype which resembles Src-transformed cells, while overexpression of wild-type AFAP-110 has no eect on actin structures (Qian et al., 1998 (Qian et al., , 2000 .
Cells expressing AFAP-110
Dlzip consistently displayed actin-rich rosettes in place of actin ®laments, as well as actin-rich lamellipodia. Filopodia are also detected in some of these cells. GFP-tagged AFAP-110 expressed in C3H10T1/2 cells co-localizes with actin ®laments and the cell membrane (Figure 1a,b) , while GFP-AFAP-110
Dlzip co-localizes with and induces the formation of actin ®lament rich-rosettes (white arrowheads, c,d) and lamellipodia (gray arrowheads, c,d). Lamellipodia were noted as actin-rich structures at the cell membrane of variable size. GFP expressed alone in these cells will not co-localize with actin ®laments or aect cytoskeletal structures (Qian et al., 2000) . Similar results were also detected in Cos-1 ®broblasts (data not shown). These data indicate that the leucine zipper plays a regulatory role for AFAP-110 and indicate that AFAP-110 also has an intrinsic ability to reposition actin ®laments into rosettes and generate lamellipodia formation when the leucine zipper is no longer present. 
Expression of AFAP-110
Dlzip directs an increase in cellular tyrosine phosphorylation
As AFAP-110
Dlzip induces a phenotype which resembles Src activation, we sought to determine if this mutant could alter actin ®laments by activating cellular kinases. Phosphoamino acid analysis was performed on AFAP-110 and AFAP-110
Dlzip from transfected Cos-1 cells. Under equal loading conditions, over-expressed AFAP-110 Dlzip contains elevated levels of serine, threonine, and tyrosine phosphorylation, compared to over-expressed wild-type AFAP-110 (Figure 2a ). Phosphorylation was increased by 1.6-, 2.6-and 2.4-fold, respectively, as determined by scanning densitometry. An additional experiment using showed similar results, with incorporation of phosphate into this mutant increased over wild-type AFAP-110 by 2.6-, 3.6-, and 3.5-fold for serine, threonine, and tyrosine, respectively. Anti-phosphotyrosine antibodies were used for Western blot analysis of immunoprecipitated proteins to con®rm the increase in tyrosine phosphorylation levels of AFAP-110
Dlzip relative to AFAP-110 ( Figure   2b ). Also, GFP-tagged forms of AFAP-110 demonstrated levels of phosphotyrosine similar to their untagged counterparts (data not shown). These data indicate that AFAP-110 Dlzip becomes hyperphosphorylated on serine, threonine, and tyrosine residues, relative to wild-type AFAP-110.
AFAP-110
Dlzip expression activates cellular tyrosine phosphorylation
The increases in tyrosine phosphorylation of AFAP-110
Dlzip indicated that it may induce the activation of cellular kinases. Anti-phosphotyrosine antibodies were used to determine if total cellular tyrosine phosphorylation was increased and to which subcellular sites tyrosine substrates were localized in these cells. Figure  3 demonstrates the results obtained using immunouorescence of transiently transfected C3H10T1/2 cells. Anti-phosphotyrosine immunolabeling revealed no signi®cant change in phosphotyrosine levels in GFP-AFAP-110 transfected cells; however, an overall increase in tyrosine phosphorylation throughout the cell, as well as a co-localization of phosphotyrosine containing proteins with GFP-AFAP-110
Dlzip and actinrich structures at the cell membrane, was evident in GFP-AFAP-110
Dlzip transfected cells, relative to untransfected cells (Figure 3d ± f, white arrowheads). Similar results were seen in Cos-1 cells (data not shown). It is noteworthy that some labeling of tyrosine phosphorylated proteins with the anti-phosphotyrosine antibody was apparent along the cell membrane and in actin-rich structures in non-transfected cells; however, the intensity of immunolabeling was signi®cantly lower than AFAP-110
Dlzip expressing cells. These structures appeared to represent lamellipodia, which are known to contain tyrosine phosphorylated proteins and whose formation and extension involve Src activation (Boschek et al., 1981; Schwartzberg et al., 1997) . The levels of immunostaining for these tyrosine phosphorylated proteins was also noticeably lower in cells expressing wild-type AFAP-110, which was equivalent to untransfecteded cells (Figure 3a ± c). These results demonstrate an increase in cellular tyrosine phosphorylated substrates along the cell membrane and within actin-rich structures in response to the expression of GFP-AFAP-110
Dlzip expression results in the specific activation of Src family kinases Speci®c Src family activation-state antibodies were used to determine if AFAP-110
Dlzip aected autophosphorylation of Src family kinases, an indicator for activation of these tyrosine kinases. Immuno¯uor-escence analysis of C3H10T1/2 cells expressing GFP-AFAP-110 revealed no signi®cant increase in immunoreactivity compared to untransfected cells, as shown in Figure 4a ± c. However, co-localization of these activated Src family members with GFP-AFAP-110 Dlzip and actin-rich structures at the cell membrane was evident (Figure 4d ± f, white arrowheads). These cells Dlzip can direct autophosphorylation of one or more Src family kinases throughout the cell and speci®cally in actin-rich structures that co-localize with GFP-AFAP-110 Dlzip along the cell membrane.
A mutation which alters the SH3-binding motif in AFAP-110 prevents AFAP-110
Dlzip from activating tyrosine kinases or altering actin filament integrity Because some SH3-binding partners can activate Srcfamily kinases via SH3 binding (Moare® et al., 1997) , it was hypothesized that AFAP-110
Dlzip may be able to activate Src-family kinases in a similar manner, as AFAP-110 is also an SH3-binding partner for cSrc, cFyn or cLyn (Flynn et al., 1993; Guappone and Flynn, 1997) . To test this, AFAP-110 P71A/Dlzip was created, which contains an additional point mutation in the SH3-binding motif that has been shown to abrogate SH3 interactions with Src, and also prevents Src/AFAP-110 stable complex formation (Guappone and Flynn, 1997) . AFAP-110 P71A/Dlzip was expressed in C3H10T1/2 cells to examine the ability of this mutant to activate Src family kinases. This mutant failed to induce an increase in cellular tyrosine phosphorylation (Figure 5a ± c) (Figure 3 ). AFAP-110 P71A/Dlzip also failed to alter actin ®laments or induce lamellipodia formation, while maintaining co-localization with actin ®laments. Thus, SH3 domain binding by AFAP-110 Dlzip appears to be necessary for its ability to activate cellular tyrosine phosphorylation, Src family kinases and cytoskeletal rearrangements.
The integrity of the PH domain of AFAP-110 is also required for AFAP-110
Dlzip -directed increases in cellular tyrosine phosphorylation, Src family activation and cytoskeletal rearrangements
GFP-AFAP-110
D180 ± 226/Dlzip contains an additional deletion of 46 amino acids in the amino-terminal PH domain, which is predicted to disrupt the function of this domain. Dlzip (data not shown). Similar results were seen in Cos-1 cells. Thus, the amino-terminal PH domain of AFAP-110 also plays an important role in the ability of AFAP-110
Dlzip to activate Src and alter actin ®lament integrity.
AFAP-110
Dlzip alters actin filaments in a Rho-dependent fashion
The GTP-binding protein, Rho, plays an important role in eecting changes in actin ®laments downstream of Src. Activated Rho can restore actin ®lament organization in Src-transformed cells (Mayer et al., 1999) , and cSrc activation requires the inactivation of Rho, by enhancing GTPase activity, to induce actin ®lament dissolution (Fincham et al., 1999) .
GFP-AFAP-110
Dlzip was co-expressed in C3H10T1/2 cells with dominant positive Rho (RhoA
V14 ) to determine if GFP-AFAP-110
Dlzip may exert its aects on actin ®laments in a Rho-dependent fashion. Cells expressing GFP-AFAP-110 and RhoA V14 were consistently ®lled with well-developed actin ®laments (Figure 7a ± c) . Similar results were seen in Cos-1 cells (data not shown). Interestingly, in GFP-AFAP-110
Dlzip expressing cells, RhoA V14 largely overcomes the ability of GFP-AFAP-110
Dlzip to reposition actin ®laments into rosettes (Figure 7d ± f) , consistent with previous results that demonstrated signi®cantly increased amounts of F-actin (Ridley and Hall, 1992) 
. It is noteworthy that GFP-AFAP-110
Dlzip is more prominently represented along the cell membrane and within small membrane protrusions, while less well associated with stress ®laments, compared to AFAP-110 co-expressed with RhoA
V14
. Additionally, these cells display some actin rosettes. Both GFP-AFAP-110
Dlzip and actin are found in these structures, albeit at levels signi®cantly lower than in cells not expressing RhoA
. These results demonstrate that the ability of AFAP-110 Dlzip to reposition actin ®laments into rosettes occurs in a Rho-dependent fashion, and, like Src, may require the down-regulation of Rho to complete this function. To con®rm that AFAP-110 Dlzip activation of Src is responsible for these changes in actin ®laments and not a consequence of changes in actin ®lament integrity, C3H10T1/2 cells were co-transfected as above and examined for tyrosine phosphorylation levels and Src family kinase activation. 
Discussion
The actin-binding protein, Src binding partner and substrate AFAP-110 has been proposed to function as a mediator of cytoskeletal rearrangements in response to Src activation (Flynn et al., 1993; Kanner et al., 1991) . AFAP-110 receives cellular signals, as it is hyperphosphorylated on serine, threonine, and tyrosine residues in Src-transformed cells (Kanner et al., 1991) . Previous reports have also shown that AFAP-110 binds F-actin structures directly, indicating that it could also aect actin ®lament integrity, directly (Qian et al., 2000) . Additional studies demonstrated that AFAP-110 self-associates via a mechanism involving a carboxy terminal, leucine zipper motif, indicating the potential for AFAP-110 to cross-link actin ®laments (Qian et al., submitted) . Co-expression of Src 527F will induce a conformational change in AFAP-110 that abrogates self-associations through the leucine zipper motif.
Thus, AFAP-110
Dlzip represents a model system or approximation of the conformation of AFAP-110 as detected in Src 527F -transformed cells. Interestingly, signals generated by Src 527F that aect the conformation of AFAP-110 appear to be the result of serine/ threonine phosphorylation, rather than tyrosine phosphorylation (Qian et al., 1998) . The changes in conformation that abrogate self-association through the leucine zipper will also occur in response to PMA treatment and activation of PKC, while inhibitors of PKC block these changes in conformation in response to Src 527F or PMA. These data indicate that cellular signals generated downstream of Src 527F , possibly involving PKC, will enable a conformational change that reduces the ability of AFAP-110 to multimerize via its leucine zipper motif. It is noteworthy that deletion of the leucine zipper motif also enables AFAP-110
Dlzip to reposition actin ®laments into rosettes, not unlike the eects of Src 527F or PMA treatment on cells. Thus, conformational changes that aect AFAP-110 in response to cellular signals may enable it to direct changes in actin ®lament organization. However, because AFAP-110 both binds actin ®laments directly and is a binding partner for signaling proteins, it was unclear whether these changes in actin ®lament integrity were the result of direct or indirect eects of AFAP-110
Dlzip upon the actin-based cytoskeleton. The data generated here demonstrate that AFAP-110 Dlzip can direct upregulation of cellular tyrosine phosphorylation and the activation state of Src-family kinases, based on immunoreactivity in these cells using phosphorylation-speci®c antibodies. In addition, the changes in actin ®lament integrity that result in actin rosette formation occur in a Rho-dependent fashion, indicating that AFAP-110
Dlzip can eect actin ®lament, rosette and lamellipodia formation by an indirect mechanism involving activation of cellular signaling cascades known to control actin ®lament dynamics.
One possible mechanism by which AFAP-110
Dlzip could activate tyrosine kinases like cSrc might be through its ability to function as an SH2/SH3 binding partner (Flynn et al., 1993; Guappone et al., 1998; Guappone and Flynn, 1997; Kanner et al., 1991; Reynolds et al., 1989) . It has been shown the SH3 binding partners, such as the HIV encoded gene Dlzip (d), and HA-tagged RhoA V14 (b,e), demonstrate abundant actin ®laments (c,f), and both AFAP-110 constructs co-localize with these structures. GFP-AFAP-110
Dlzip colocalizes with actin-rich structures at the cell membrane, as denoted by the white arrowheads (d,f) (4100 cells examined) product, Nef, can activate the Src family member Hck via SH3 binding (Briggs et al., 1997; Moare® et al., 1997) . It has also been demonstrated that intramolecular interactions that keep Src or Hck in the repressed conformation involve the SH3 domain binding to a left-handed, polyproline type II helix in the linker domain (Liu and Pawson, 1994) . Nef, by virtue of its ability to function as an SH3 binding partner for Hck, is able to displace the intramolecular SH3 interaction of Hck and subsequently direct activation of the kinase. Similarly, it is possible that within the conformation represented by AFAP-110 Dlzip , AFAP-110 becomes a more favorable SH3-binding partner for Src and may activate Src-family members by a similar mechanism. This hypothesis is supported by the results which indicate that SH3 interactions are necessary for Dlzip to activate Src family kinases and induce cytoskeletal rearrangements ( Figure 5) . Additionally, the ability of RhoA V14 to block the ability of AFAP-110
Dlzip to rearrange the actin cytoskeleton (Figure 7) indicates that the actions of AFAP-110 Dlzip on the cytoskeleton are a result of activating signaling cascades through Src to Rho family GTPases ( Figure  9 ).
The abrogation of hyperphosphorylation and the cytoskeletal reorganization induced in cells expressing Dlzip by the additional deletion in the PH domain indicates that this domain may also play a signi®cant role in the action of AFAP-110 toward the actin cytoskeleton. It is possible that this loss of function occurs due to the interruption of interactions with one or more potential PH domain binding partners, rather than due to a change in subcellular localization. This interpretation is based on the observation that GFP-AFAP-110 D180 ± 226/Dlzip is detected on the cell membrane, similar to wild-type AFAP-110. The amino terminal PH domain is also capable of anity absorbing several binding partners from cellular lysate, including PKC (Baisden et al., in preparation) . This interaction is abrogated by deletion of residues , and less associated with stress ®laments. Recent data from our laboratory indicated that AFAP-110
Dlzip does exert direct eects upon actin ®laments by increasing actin ®lament cross-linking, in vitro (Qian et al., in preparation) . It may be possible that AFAP-110
Dlzip also has an ability to eect actin ®lament cross-linking as a consequence of direct interactions and, thus, this capability could be ampli®ed in the presence of RhoA V14 . In this study, we demonstrate a potential mechanism by which AFAP-110
Dlzip can mediate changes in actin ®lament integrity by activation of cellular tyrosine kinases. These results indicate that AFAP-110 Dlzip repositions actin ®laments into rosettes by an indirect mechanism which activates cellular kinases in an SH3-binding and PH-binding dependent fashion. We predict that upstream cellular signals can alter the conformation of AFAP-110, enabling to activate cellular tyrosine kinases, such as Src-family kinases. The nature of the upstream cellular signals that eect AFAP-110 may also involve activation of PKC family members. Unpublished data from our laboratory demonstrate that AFAP-110 is a substrate for PKC and that changes in conformation detected within AFAP-110 in response to Src 527F signaling occur in a PKC-dependent fashion (Baisden et al., in preparation) . Thus, we hypothesize that AFAP-110 may be a cSrc-activating protein and this intrinsic ability may be revealed by upstream cellular signals that alter the conformation of AFAP-110 and present it as a more favorable SH3-binding partner to Src-family kinases, such as cSrc or cFyn. This could result in the activation of these signaling cascades and the concomitant changes in actin ®lament integrity. Ultimately, activation of this signaling cascade may direct activation of Rho-family GTPases which exert their eects upon the actin-based cytoskeleton.
Materials and methods

Reagents
Dulbecco's modi®ed Eagle's medium, Basal Medium Eagle, and Rhodamine-phalloidin were obtained from Sigma. AFAP-110 antibodies 4C3 and F1 were generated and characterized as previously described (Qian et al., 1999) . Anti-phosphotyrosine was purchased from BD Transduction Labs. Anti-phospho-Src (Y 416 ) was purchased from Cell Signaling (Massachusetts, USA). Anti-rabbit Alexa 633 and anti-mouse Alexa 488 were obtained from Molecular Probes. Anti-HA tag antibody was purchased from Santa Cruz Biotechnology.
Cell Culture
Cos-1 cells were maintained and transfected as previously described (Guappone and Flynn, 1997) . C3H10T1/2 cells were cultured as previously described (Qian et al., 2000) . Transient transfections of C3H10T1/2 cells were carried out using Eectene (Qiagen) as per manufacturers instructions. Transient transfections of Cos-1 cells employed the CalPhos transfection kit (Clontech).
Phosphoamino acid analysis
Cos-1 cells were grown to 60% con¯uence in 100 mm culture dishes, and transiently transfected. After 48 h, the cells were serum starved overnight in phosphate free media supplemented with 2.5 mCi 32 P-orthophosphate (Amersham). Cells were washed twice with PBS and lysed with 1 ml RIPA buer, as previously described (Qian et al., 1998) . One and one-half ml monoclonal antibody 4C3 ascites was used to immunoprecipitate AFAP-110 from the lysate, which was isolated via SDS ± PAGE. The radioactive band was excised from the gel and subjected to partial acid hydrolysis and phosphoamino acid analysis (Boyle et al., 1991) . During this analysis, samples were monitored with a scintillation counter during Figure 9 Model of the pathway of activation of cellular kinases by AFAP-110 in response to the conformational change induced by cellular signals or deletion of the leucine zipper. Dashed arrows indicate speci®c events; solid arrows show the activation of these events each step to check for loss, which was similar for both AFAP-110 and AFAP-110 Dlzip . After running the isolated amino acids on 2D TLC, the plates were imaged using a Phosphorimager (Molecular Dynamics). Spots were identi®ed by running labeled phosphoserine, phosphothreonine and phosphotyrosine markers. Relative intensity compared to background of radiation from spots was quantitated with ImageQuant software.
Immunofluorescence
C3H10T1/2 cells were transiently transfected, as above. Forty-eight hours after transfections, the cells were serumstarved overnight. Cells were ®xed and permeabalized as previously described (Qian et al., 1998) . After washing, cells were labeled for 30 min. For actin labeling, a 1 : 1000 dilution of rhodamine-phalloidin was used. Antibody concentrations used: 4C3, 0.6 mg/ml in 5% BSA; Anti-HA, 4 mg/ml in 5% BSA; anti-phosphotyrosine, 2.5 mg/ml in 5% BSA; antiphospho-Src (Y 416 ) labeling, 5 ml/ml in 5% BSA. Both polyclonal phospho-speci®c antibodies were visualized by incubating the cells for 30 min with anti-rabbit-Alexa 633 (5 ml/ml in 5% BSA) after washing o primary antibody. Monoclonal antibody 4C3 was visualized using Alexa 488 anti-mouse secondary antibody (5 ml/ml in 5% BSA). Cells were washed and mounted on slides with Fluoromount (Fisher). A Zeiss LSM 510 microscope was used to gather grayscale images, which represent confocal slices of about 2 mM in thickness. Scale bars were generated and inserted by LSM 510 software.
